These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1954061)

  • 1. Intravenous haloperidol for tranquilization in critical care patients: a review and critique.
    Ziehm SR
    AACN Clin Issues Crit Care Nurs; 1991 Nov; 2(4):765-77. PubMed ID: 1954061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome in the intensive care unit.
    Sing RF; Branas CC; Marino PL
    J Am Osteopath Assoc; 1993 May; 93(5):615-8. PubMed ID: 8314724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of haloperidol in agitated, critically ill patients.
    Stern TA
    Crit Care Med; 1994 Mar; 22(3):378-9. PubMed ID: 8124985
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of haloperidol in the agitated, critically ill pediatric patient with burns.
    Brown RL; Henke A; Greenhalgh DG; Warden GD
    J Burn Care Rehabil; 1996; 17(1):34-8. PubMed ID: 8808357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol.
    Bellamy CJ; Kane-Gill SL; Falcione BA; Seybert AL
    J Trauma; 2009 Mar; 66(3):954-8. PubMed ID: 19276778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of haloperidol infusions to control delirium in critically ill adults.
    Seneff MG; Mathews RA
    Ann Pharmacother; 1995; 29(7-8):690-3. PubMed ID: 8520081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome with intravenous haloperidol.
    Levitt AJ; Midha R; Craven JL
    Can J Psychiatry; 1990 Dec; 35(9):789. PubMed ID: 2282634
    [No Abstract]   [Full Text] [Related]  

  • 8. Continuous infusion of haloperidol controls agitation in critically ill patients.
    Riker RR; Fraser GL; Cox PM
    Crit Care Med; 1994 Mar; 22(3):433-40. PubMed ID: 8124994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of haloperidol and associated complications in the agitated, acutely ill pediatric burn patient.
    Ratcliff SL; Meyer WJ; Cuervo LJ; Villarreal C; Thomas CR; Herndon DN
    J Burn Care Rehabil; 2004; 25(6):472-8. PubMed ID: 15534454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome and cardiac surgery. A case report.
    Sirois F
    J Cardiovasc Surg (Torino); 2008 Oct; 49(5):695-6. PubMed ID: 18670390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous infusions of haloperidol in critically ill patients.
    Crippen D; Ermakov S
    Crit Care Med; 1995 Jan; 23(1):214-5. PubMed ID: 8001379
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients.
    Tesar GE; Murray GB; Cassem NH
    J Clin Psychopharmacol; 1985 Dec; 5(6):344-7. PubMed ID: 4067002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial.
    Asadollahi S; Heidari K; Hatamabadi H; Vafaee R; Yunesian S; Azadbakht A; Mirmohseni L
    Int Clin Psychopharmacol; 2015 May; 30(3):142-50. PubMed ID: 25500684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome in a trauma patient.
    Burke C; Fulda GJ; Castellano J
    J Trauma; 1995 Oct; 39(4):796-8. PubMed ID: 7473981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe, refractory agitation with a haloperidol drip.
    Fernandez F; Holmes VF; Adams F; Kavanaugh JJ
    J Clin Psychiatry; 1988 Jun; 49(6):239-41. PubMed ID: 3379030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome complicating closed head injury.
    Vincent FM; Zimmerman JE; Van Haren J
    Neurosurgery; 1986 Feb; 18(2):190-3. PubMed ID: 3960297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines.
    Menza MA; Murray GB; Holmes VF; Rafuls WA
    Heart Lung; 1988 May; 17(3):238-41. PubMed ID: 2896642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for torsade de pointes: a comparative, case-based evaluation.
    Fongemie JM; Al-Qadheeb NS; Estes NA; Roberts RJ; Temtanakitpaisan Y; Ruthazer R; Devlin JW
    Pharmacotherapy; 2013 Jun; 33(6):589-97. PubMed ID: 23529904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute extrapyramidal syndrome and neuroleptical malignant syndrome. A case report].
    Cesario V
    Recenti Prog Med; 2008 Mar; 99(3):146-8. PubMed ID: 18488526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill.
    Metzger E; Friedman R
    J Clin Psychopharmacol; 1993 Apr; 13(2):128-32. PubMed ID: 8463445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.